RecruitingNot ApplicableNCT06553612

Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer


Sponsor

Centre Francois Baclesse

Enrollment

268 participants

Start Date

Jun 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French trial is testing whether a comprehensive day-hospital assessment — including physical, psychological, and social support — after finishing initial cancer treatment helps women with ovarian or endometrial cancer actually receive the supportive care recommended in their personalized post-cancer plans, compared to standard follow-up care. **You may be eligible if...** - You are 18 or older and in remission after completing first-line treatment for ovarian, peritoneal, or endometrial cancer - You are in France and speak French - You have access to a telephone and are enrolled in social security - Patients on maintenance therapy are also eligible **You may NOT be eligible if...** - You have a medical or psychiatric condition that would prevent participation - Your cancer has returned or spread (recurrence or metastases) - You are simultaneously enrolled in another therapeutic clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultidisciplinary assessment

Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital

OTHERStandard assesment

Delivery of a personalized post-cancer plan without a day hospital

OTHERObservational cohort

Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort


Locations(13)

CHU, Besançon

Besançon, France

François Baclesse

Caen, France

Centre Jean Perrin

Clermont-Ferrand, France

Centre Léon Bérard

Lyon, France

Hopital Diaconesses Croix Saint-Simon

Paris, France

Hopital Europeen George Pompidou

Paris, France

Hôpital COCHIN

Paris, France

Institut Curie

Paris, France

Hopital privé des Côtes d'Armor

Plérin, France

Institut Curie, St Cloud

Saint-Cloud, France

CHU, Saint Etienne

Saint-Etienne, France

CHU

Strasbourg, France

Gustave Roussy

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06553612


Related Trials